Abstract | OBJECTIVE: CASE REPORT: A 17-year-old transgender boy presented with breast development after having been on a GnRH agonist and then testosterone since the age of 11 years, having never experienced breast development before, which was consistent with pubertal gynecomastia. A small decrease in the testosterone dose resulted in a significant reduction of gynecomastia. Despite the improvement, he went on to undergo chest surgery with the removal of the breast tissue. DISCUSSION: Pubertal gynecomastia is a common phenomenon in the cisgender male population. However, it has not been previously described in transgender boys. The potential mechanisms for its occurrence were discussed. CONCLUSION:
|
Authors | Raymond Fung, Mary Kathleen Greenaway, Giancarlo McEvenue |
Journal | AACE clinical case reports
(AACE Clin Case Rep)
2021 Nov-Dec
Vol. 7
Issue 6
Pg. 350-352
ISSN: 2376-0605 [Electronic] United States |
PMID | 34765730
(Publication Type: Case Reports)
|
Copyright | © 2021 AACE. Published by Elsevier Inc. |